Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
9 June, 2025•10 min
0
9 June, 2025•10 min
0
More in Business
Business
Is Jubilant a victim of its own success?
As a consistent performer—proved once again by its stellar Q3 FY26 results—the QSR giant runs smack dab into a market fixated on its ‘tough base’.
You may also like
Business
The weight-loss wave that’s changing India—one sector at a time
Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
Business
News explainers that stood out in 2024
Bluesky vs X, the UAE deluge, Adar Poonawalla’s investment in Karan Johar’s Dharma Productions and more.
